Development of a theragnostic system for the treatment of Gram-negative bacterial infections of the lung

PneumoNP is a collaborative research program funded under the Seventh Framework Programme, with a €5.7 million grant. Starting in 2014, it is aiming at the development of a theragnostic system for the treatment of Gram-negative bacterial infections of the lung, with focus on Klebsiella pneumoniae caused infections.

 
 

Latest news from PneumoNP

cropped-Logo_PneumoNP_Simple_PRINT-01.png

New publication: Synthesis of Single–Chain Nanoparticles in Aqueous Media

Synthesis and Functionalization of Dextran–Based Single–Chain Nanoparticles in Aqueous Media Abstracts Water-dispersible dextran-based single-chain polymer nanoparticles (SCPNs) were prepared in ...
Read More
PET image

Imaging data reveals nanomedicines in lungs

An experiment carried out in Spain shows the distribution of an inhaled nanomedicine in rat lungs. The PneumoNP project aims ...
Read More